Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population-Reference-Cited by-同舟云学术

Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population

Published:2020-02 Issue: Volume:174 Page:104698
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Choi Debra T.,Puenpatom Amy,Yu Xian,Erickson Kevin F.,Kanwal Fasiha,El-Serag Hashem B.,Kramer Jennifer R.

Funder

Department of Veterans Affairs

Office of Research and Development

NIH

Merck Sharp & Dohme Corp.

Merck & Co., Inc.

Merck Sharp & Dohme Corp

Merck & Co

Gilead Sciences

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference29 articles.

1. Elbasvir/grazoprevir: a Review in chronic HCV genotypes 1 and 4;Al-Salama;Drugs,2017

2. Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial;Bruchfeld;Lancet Gastroenterol Hepatol,2017

3. Insights from advanced analytics at the veterans health administration;Fihn;Health Aff.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized care approaches to hepatitis C therapy: recent advances and future directions;Expert Review of Anti-infective Therapy;2024-03-11

2. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

3. Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-06-04

4. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

5. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01